Tag: COVID-19
What can Biobanks Learn From the Current Pandemic?
More than a year ago, something happened that most of us could hardly imagine. A virus took the whole world more or less firmly in its grip. Pandemic, previously a word that very few of us knew, has now...
Interview with Dr. Tony Cox OBE, CEO at UK Biocentre
UK Biocentre is a not-for-profit organisation providing world-leading sample management and high-capacity bioprocessing services to biomedical researchers. They provide sample collection, sample logistics, processing, nucleic acidic extraction, sample storage, and shipping management. UK Biocentre is currently commissioned by the UK...
Complement And Coagulation Disorders Associated With COVID-19
Recent structure based comparisons suggest that coronavirus proteins mimic at least 140 human proteins, including those in the complement and coagulation pathways. The complement cascade leading to cell death and inflammation is part of the innate immune system, and...
Genetics Of Susceptibility To Viral Infection
The severity of infectious diseases vary from person to person partly due to individual genetic factors. This can shape genetics at the population level, for example inherited sickle cell disease can protect against malarial infection, and is therefore advantageous...
COVID-19 Risk In Different Ethnic And Socioeconomic Groups Within UK Biobank
Socioeconomic and ethnic factors may influence the risk of viral infection. For example, both economic circumstances and cultural influences may impact the extent to which people can implement distancing measures, thus modifying their risk. The extent to which this...
Vitamin D Status Did Not Predict COVID-19 Infection Risk In The UK Biobank
A recent meta-analysis of 25 clinical trials located in 15 countries conducted by the UK National Health Service (NHS), Institute for Health Research, indicated that vitamin D supplements reduced the risk of acute respiratory infection (ARI) from 42% to...
SARS-CoV-2 Detected In French Biobank Sample Collected In Late 2019
COVID-19 is a respiratory disease pandemic that has swept across the world, causing over 282,495 deaths (May 10, 2020). Patients most commonly present at hospitals with influenza-like illness (ILI). The causative agent of COVID-19, the coronavirus SARS-CoV-2, has no...
CloudLIMS Redefines Operations in COVID-19 Biobanks with its Ready-to-go-live COVID-19 LIMS
Wilmington, Delaware – May 08, 2020, CloudLIMS, a leading provider of laboratory informatics, announces the launch of a ready-to-go-live COVID-19 LIMS. CloudLIMS is preconfigured with CDC approved COVID-19 biorepository SOPs and can be quickly set up in less than a week. With...
Safety for Biobanks: Strategies for Safe COVID-19 Specimens Handling
The COVID-19 pandemic has spread to almost every country around the world. In less than 4 months, this new disease has affected more than 1,800,000 people and caused almost 120,000 deaths. There are no effective treatments or vaccines for...
AgileBio Launces a LIMS Package Addressed to COVID-19 Labs
Paris - March 27, 2020. Solidarity is the need of the pressing COVID-19 situation today. LabCollector LIMS solution is ready to join hands with the testing labs to increase the rapidity and efficiency of COVID-19 tests and its management...
